Skip to content
2000
image of Comprehensive Analysis of TSPAN11: A Potential Prognostic and Immunotherapy Biomarker in Colorectal Cancer

Abstract

Introduction

Colorectal cancer (CRC) remains a significant global health challenge due to its high incidence and mortality rates. The disease's complexity and heterogeneity impede early diagnosis and effective treatment. The study aims to investigate the role of Tetraspanin 11 (TSPAN11) in CRC, exploring its potential as a prognostic biomarker and immunotherapy target through bioinformatics analysis and experimental validation.

Methods

Pan-cancer patient data were obtained from The Cancer Genome Atlas (TCGA) and the GSE71187 dataset, including 672 CRC tissues and 51 adjacent normal tissues. Differential expression analysis, Kaplan-Meier survival analysis, gene set enrichment analysis (GSEA), and immune infiltration assessment were performed. TSPAN11 expression was validated in CRC cell lines using quantitative reverse transcription PCR (qRT-PCR).

Results

TSPAN11 was significantly downregulated in CRC tissues compared to normal tissues (p < 0.001), with lower expression associated with poorer overall survival (OS; p = 0.011) and disease-specific survival (DSS; p = 0.038). Multivariate analysis identified TSPAN11 as an independent prognostic factor (p = 0.045). TSPAN11 expression was linked to key pathways such as ECM receptor interaction and TGF-β signaling, and correlated with immune infiltration, immune checkpoint genes, tumor mutational burden (TMB), microsatellite instability (MSI), and drug sensitivity.

Discussion

The findings suggest that TSPAN11 may influence CRC progression through multiple biological pathways and immune-related mechanisms. Its downregulation is associated with poorer prognosis and immune evasion, highlighting its potential as a biomarker and therapeutic target. However, validation in larger cohorts and elucidation of underlying mechanisms are needed to confirm these results and translate them into clinical practice.

Conclusion

TSPAN11 may serve as a promising prognostic biomarker and immunotherapy target in CRC. Its associations with clinical outcomes, immune features, and drug sensitivity underscore its potential for improving CRC diagnosis and treatment strategies.

© 2025 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/ctmc/10.2174/0115680266392910250728013705
2025-08-06
2025-09-12

  • From This Site

    /content/journals/ctmc/10.2174/0115680266392910250728013705
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. Lu S. Sun X. Tang H. Yu J. Wang B. Xiao R. Qu J. Sun F. Deng Z. Li C. Yang P. Yang Z. Rao B. Colorectal cancer with low SLC35A3 is associated with immune infiltrates and poor prognosis. Sci. Rep. 2024 14 1 329 10.1038/s41598‑023‑51028‑w 38172565
    [Google Scholar]
  2. Erratum: Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 2020 70 4 313 10.3322/caac.21609 32767693
    [Google Scholar]
  3. Li N. Lu B. Luo C. Cai J. Lu M. Zhang Y. Chen H. Dai M. Incidence, mortality, survival, risk factor and screening of colorectal cancer: A comparison among China, Europe, and northern America. Cancer Lett. 2021 522 255 268 10.1016/j.canlet.2021.09.034 34563640
    [Google Scholar]
  4. Liu S. Zheng R. Zhang M. Zhang S. Sun X. Chen W. Incidence and mortality of colorectal cancer in China, 2011. Chin. J. Cancer Res. 2015 27 1 22 28 10.1007/BF02954997 25717222
    [Google Scholar]
  5. Siegel R.L. Miller K.D. Fedewa S.A. Ahnen D.J. Meester R.G.S. Barzi A. Jemal A. Colorectal cancer statistics, 2017. CA Cancer J. Clin. 2017 67 3 177 193 10.3322/caac.21395 28248415
    [Google Scholar]
  6. Molinari C. Marisi G. Passardi A. Matteucci L. De Maio G. Ulivi P. Heterogeneity in colorectal cancer: A challenge for personalized medicine? Int. J. Mol. Sci. 2018 19 12 3733 10.3390/ijms19123733 30477151
    [Google Scholar]
  7. Fanelli G.N. Dal Pozzo C.A. Depetris I. Schirripa M. Brignola S. Biason P. Balistreri M. Dal Santo L. Lonardi S. Munari G. Loupakis F. Fassan M. The heterogeneous clinical and pathological landscapes of metastatic Braf -mutated colorectal cancer. Cancer Cell Int. 2020 20 1 30 10.1186/s12935‑020‑1117‑2 32015690
    [Google Scholar]
  8. Becic A. Leifeld J. Shaukat J. Hollmann M. Tetraspanins as potential modulators of glutamatergic synaptic function. Front. Mol. Neurosci. 2022 14 801882 10.3389/fnmol.2021.801882 35046772
    [Google Scholar]
  9. Zhang H. Song Q. Shang K. Li Y. Jiang L. Yang L. Tspan protein family: Focusing on the occurrence, progression, and treatment of cancer. Cell Death Discov. 2024 10 1 187 10.1038/s41420‑024‑01961‑0 38649381
    [Google Scholar]
  10. Huang R. Sun H. Lin R. Zhang J. Yin H. Xian S. Li M. Wang S. Li Z. Qiao Y. Jiang M. Yan P. Meng T. Huang Z. The role of tetraspanins pan-cancer. iScience 2022 25 8 104777 10.1016/j.isci.2022.104777 35992081
    [Google Scholar]
  11. Dong Y. Jin F. Wang J. Li Q. Huang Z. Xia L. Yang M. SFXN3 is associated with poor clinical outcomes and sensitivity to the hypomethylating therapy in non-M3 acute myeloid leukemia patients. Curr. Gene Ther. 2023 23 5 410 418 10.2174/1566523223666230724121515 37491851
    [Google Scholar]
  12. Huang Z. Hu X. Wei Y. Lai Y. Qi J. Pang J. Huang K. Li H. Cai P. ADAMTSL2 is a potential prognostic biomarker and immunotherapeutic target for colorectal cancer: Bioinformatic analysis and experimental verification. PLoS One 2024 19 5 e0303909 10.1371/journal.pone.0303909 38814950
    [Google Scholar]
  13. Chen R. Duan J. Ye Y. Xu H. Ding Y. Liu J. Identification and verification of a prognostic risk signature in oral squamous cell carcinoma. Curr. Top. Med. Chem. 2024 ••• 24 10.2174/0115680266335055240828061128 39238386
    [Google Scholar]
  14. Han Q. Cui Z. Wang Q. Pang F. Li D. Wang D. Upregulation of OTX2-AS1 is associated with immune infiltration and predicts prognosis of gastric cancer. Technol. Cancer Res. Treat. 2023 22 15330338231154091 10.1177/15330338231154091 36740995
    [Google Scholar]
  15. Liang W. Lu Y. Pan X. Zeng Y. Zheng W. Li Y. Nie Y. Li D. Wang D. Decreased expression of a novel lncRNA FAM181A-AS1 is associated with poor prognosis and immune infiltration in lung adenocarcinoma. Pharm. Genomics Pers. Med. 2022 15 985 998 10.2147/PGPM.S384901 36482943
    [Google Scholar]
  16. Wang J. Dai W. Zhang M. GATA3 positively regulates PAR1 to facilitate in vitro disease progression and decrease cisplatin sensitivity in neuroblastoma via inhibiting the hippo pathway. Anticancer Drugs 2023 34 1 57 72 10.1097/CAD.0000000000001341 35946556
    [Google Scholar]
  17. Pan H. Liu Q. Zhang F. Wang X. Wang S. Shi X. High STK40 expression as an independent prognostic biomarker and correlated with immune infiltrates in low-grade gliomas. Int. J. Gen. Med. 2021 14 6389 6400 10.2147/IJGM.S335821 34675607
    [Google Scholar]
  18. Xue J. Song Y. Xu W. Zhu Y. The CDK1-related lncRNA and CXCL8 mediated immune resistance in lung adenocarcinoma. Cells 2022 11 17 2688 10.3390/cells11172688 36078096
    [Google Scholar]
  19. Lin Z. Huang W. Yi Y. Li D. Xie Z. Li Z. Ye M. LncRNA ADAMTS9-AS2 is a prognostic biomarker and correlated with immune infiltrates in lung adenocarcinoma. Int. J. Gen. Med. 2021 14 8541 8555 10.2147/IJGM.S340683 34849000
    [Google Scholar]
  20. Andola P. Doble M. ML-based models as a strategy to discover novel antiepileptic drugs targeting sodium receptor channel. Curr. Top. Med. Chem. 2024 25 2 209 227 10.2174/0115680266331755241008061915 39440735
    [Google Scholar]
  21. Yi W. Shen H. Sun D. Xu Y. Feng Y. Li D. Wang C. Low expression of long noncoding RNA SLC26A4 antisense RNA 1 Is an Independent prognostic biomarker and correlate of immune infiltrates in breast cancer. Med. Sci. Monit. 2022 28 e934522 10.12659/MSM.934522 34880202
    [Google Scholar]
  22. Chen J. Tang H. Li T. Jiang K. Zhong H. Wu Y. He J. Li D. Li M. Cai X. Comprehensive analysis of the expression, prognosis, and biological significance of OVOLs in breast cancer. Int. J. Gen. Med. 2021 14 3951 3960 10.2147/IJGM.S326402 34345183
    [Google Scholar]
  23. Liu J. Lichtenberg T. Hoadley K.A. Poisson L.M. Lazar A.J. Cherniack A.D. Kovatich A.J. Benz C.C. Levine D.A. Lee A.V. Omberg L. Wolf D.M. Shriver C.D. Thorsson V. Hu H. Caesar-Johnson S.J. Demchok J.A. Felau I. Kasapi M. Ferguson M.L. Hutter C.M. Sofia H.J. Tarnuzzer R. Wang Z. Yang L. Zenklusen J.C. Zhang J.J. Chudamani S. Liu J. Lolla L. Naresh R. Pihl T. Sun Q. Wan Y. Wu Y. Cho J. DeFreitas T. Frazer S. Gehlenborg N. Getz G. Heiman D.I. Kim J. Lawrence M.S. Lin P. Meier S. Noble M.S. Saksena G. Voet D. Zhang H. Bernard B. Chambwe N. Dhankani V. Knijnenburg T. Kramer R. Leinonen K. Liu Y. Miller M. Reynolds S. Shmulevich I. Thorsson V. Zhang W. Akbani R. Broom B.M. Hegde A.M. Ju Z. Kanchi R.S. Korkut A. Li J. Liang H. Ling S. Liu W. Lu Y. Mills G.B. Ng K-S. Rao A. Ryan M. Wang J. Weinstein J.N. Zhang J. Abeshouse A. Armenia J. Chakravarty D. Chatila W.K. de Bruijn I. Gao J. Gross B.E. Heins Z.J. Kundra R. La K. Ladanyi M. Luna A. Nissan M.G. Ochoa A. Phillips S.M. Reznik E. Sanchez-Vega F. Sander C. Schultz N. Sheridan R. Sumer S.O. Sun Y. Taylor B.S. Wang J. Zhang H. Anur P. Peto M. Spellman P. Benz C. Stuart J.M. Wong C.K. Yau C. Hayes D.N. Parker J.S. Wilkerson M.D. Ally A. Balasundaram M. Bowlby R. Brooks D. Carlsen R. Chuah E. Dhalla N. Holt R. Jones S.J.M. Kasaian K. Lee D. Ma Y. Marra M.A. Mayo M. Moore R.A. Mungall A.J. Mungall K. Robertson A.G. Sadeghi S. Schein J.E. Sipahimalani P. Tam A. Thiessen N. Tse K. Wong T. Berger A.C. Beroukhim R. Cherniack A.D. Cibulskis C. Gabriel S.B. Gao G.F. Ha G. Meyerson M. Schumacher S.E. Shih J. Kucherlapati M.H. Kucherlapati R.S. Baylin S. Cope L. Danilova L. Bootwalla M.S. Lai P.H. Maglinte D.T. Van Den Berg D.J. Weisenberger D.J. Auman J.T. Balu S. Bodenheimer T. Fan C. Hoadley K.A. Hoyle A.P. Jefferys S.R. Jones C.D. Meng S. Mieczkowski P.A. Mose L.E. Perou A.H. Perou C.M. Roach J. Shi Y. Simons J.V. Skelly T. Soloway M.G. Tan D. Veluvolu U. Fan H. Hinoue T. Laird P.W. Shen H. Zhou W. Bellair M. Chang K. Covington K. Creighton C.J. Dinh H. Doddapaneni H.V. Donehower L.A. Drummond J. Gibbs R.A. Glenn R. Hale W. Han Y. Hu J. Korchina V. Lee S. Lewis L. Li W. Liu X. Morgan M. Morton D. Muzny D. Santibanez J. Sheth M. Shinbro E. Wang L. Wang M. Wheeler D.A. Xi L. Zhao F. Hess J. Appelbaum E.L. Bailey M. Cordes M.G. Ding L. Fronick C.C. Fulton L.A. Fulton R.S. Kandoth C. Mardis E.R. McLellan M.D. Miller C.A. Schmidt H.K. Wilson R.K. Crain D. Curley E. Gardner J. Lau K. Mallery D. Morris S. Paulauskis J. Penny R. Shelton C. Shelton T. Sherman M. Thompson E. Yena P. Bowen J. Gastier-Foster J.M. Gerken M. Leraas K.M. Lichtenberg T.M. Ramirez N.C. Wise L. Zmuda E. Corcoran N. Costello T. Hovens C. Carvalho A.L. de Carvalho A.C. Fregnani J.H. Longatto-Filho A. Reis R.M. Scapulatempo-Neto C. Silveira H.C.S. Vidal D.O. Burnette A. Eschbacher J. Hermes B. Noss A. Singh R. Anderson M.L. Castro P.D. Ittmann M. Huntsman D. Kohl B. Le X. Thorp R. Andry C. Duffy E.R. Lyadov V. Paklina O. Setdikova G. Shabunin A. Tavobilov M. McPherson C. Warnick R. Berkowitz R. Cramer D. Feltmate C. Horowitz N. Kibel A. Muto M. Raut C.P. Malykh A. Barnholtz-Sloan J.S. Barrett W. Devine K. Fulop J. Ostrom Q.T. Shimmel K. Wolinsky Y. Sloan A.E. De Rose A. Giuliante F. Goodman M. Karlan B.Y. Hagedorn C.H. Eckman J. Harr J. Myers J. Tucker K. Zach L.A. Deyarmin B. Hu H. Kvecher L. Larson C. Mural R.J. Somiari S. Vicha A. Zelinka T. Bennett J. Iacocca M. Rabeno B. Swanson P. Latour M. Lacombe L. Têtu B. Bergeron A. McGraw M. Staugaitis S.M. Chabot J. Hibshoosh H. Sepulveda A. Su T. Wang T. Potapova O. Voronina O. Desjardins L. Mariani O. Roman-Roman S. Sastre X. Stern M-H. Cheng F. Signoretti S. Berchuck A. Bigner D. Lipp E. Marks J. McCall S. McLendon R. Secord A. Sharp A. Behera M. Brat D.J. Chen A. Delman K. Force S. Khuri F. Magliocca K. Maithel S. Olson J.J. Owonikoko T. Pickens A. Ramalingam S. Shin D.M. Sica G. Van Meir E.G. Zhang H. Eijckenboom W. Gillis A. Korpershoek E. Looijenga L. Oosterhuis W. Stoop H. van Kessel K.E. Zwarthoff E.C. Calatozzolo C. Cuppini L. Cuzzubbo S. DiMeco F. Finocchiaro G. Mattei L. Perin A. Pollo B. Chen C. Houck J. Lohavanichbutr P. Hartmann A. Stoehr C. Stoehr R. Taubert H. Wach S. Wullich B. Kycler W. Murawa D. Wiznerowicz M. Chung K. Edenfield W.J. Martin J. Baudin E. Bubley G. Bueno R. De Rienzo A. Richards W.G. Kalkanis S. Mikkelsen T. Noushmehr H. Scarpace L. Girard N. Aymerich M. Campo E. Giné E. Guillermo A.L. Van Bang N. Hanh P.T. Phu B.D. Tang Y. Colman H. Evason K. Dottino P.R. Martignetti J.A. Gabra H. Juhl H. Akeredolu T. Stepa S. Hoon D. Ahn K. Kang K.J. Beuschlein F. Breggia A. Birrer M. Bell D. Borad M. Bryce A.H. Castle E. Chandan V. Cheville J. Copland J.A. Farnell M. Flotte T. Giama N. Ho T. Kendrick M. Kocher J-P. Kopp K. Moser C. Nagorney D. O’Brien D. O’Neill B.P. Patel T. Petersen G. Que F. Rivera M. Roberts L. Smallridge R. Smyrk T. Stanton M. Thompson R.H. Torbenson M. Yang J.D. Zhang L. Brimo F. Ajani J.A. Angulo Gonzalez A.M. Behrens C. Bondaruk J. Broaddus R. Czerniak B. Esmaeli B. Fujimoto J. Gershenwald J. Guo C. Lazar A.J. Logothetis C. Meric-Bernstam F. Moran C. Ramondetta L. Rice D. Sood A. Tamboli P. Thompson T. Troncoso P. Tsao A. Wistuba I. Carter C. Haydu L. Hersey P. Jakrot V. Kakavand H. Kefford R. Lee K. Long G. Mann G. Quinn M. Saw R. Scolyer R. Shannon K. Spillane A. Stretch J. Synott M. Thompson J. Wilmott J. Al-Ahmadie H. Chan T.A. Ghossein R. Gopalan A. Levine D.A. Reuter V. Singer S. Singh B. Tien N.V. Broudy T. Mirsaidi C. Nair P. Drwiega P. Miller J. Smith J. Zaren H. Park J-W. Hung N.P. Kebebew E. Linehan W.M. Metwalli A.R. Pacak K. Pinto P.A. Schiffman M. Schmidt L.S. Vocke C.D. Wentzensen N. Worrell R. Yang H. Moncrieff M. Goparaju C. Melamed J. Pass H. Botnariuc N. Caraman I. Cernat M. Chemencedji I. Clipca A. Doruc S. Gorincioi G. Mura S. Pirtac M. Stancul I. Tcaciuc D. Albert M. Alexopoulou I. Arnaout A. Bartlett J. Engel J. Gilbert S. Parfitt J. Sekhon H. Thomas G. Rassl D.M. Rintoul R.C. Bifulco C. Tamakawa R. Urba W. Hayward N. Timmers H. Antenucci A. Facciolo F. Grazi G. Marino M. Merola R. de Krijger R. Gimenez-Roqueplo A-P. Piché A. Chevalier S. McKercher G. Birsoy K. Barnett G. Brewer C. Farver C. Naska T. Pennell N.A. Raymond D. Schilero C. Smolenski K. Williams F. Morrison C. Borgia J.A. Liptay M.J. Pool M. Seder C.W. Junker K. Omberg L. Dinkin M. Manikhas G. Alvaro D. Bragazzi M.C. Cardinale V. Carpino G. Gaudio E. Chesla D. Cottingham S. Dubina M. Moiseenko F. Dhanasekaran R. Becker K-F. Janssen K-P. Slotta-Huspenina J. Abdel-Rahman M.H. Aziz D. Bell S. Cebulla C.M. Davis A. Duell R. Elder J.B. Hilty J. Kumar B. Lang J. Lehman N.L. Mandt R. Nguyen P. Pilarski R. Rai K. Schoenfield L. Senecal K. Wakely P. Hansen P. Lechan R. Powers J. Tischler A. Grizzle W.E. Sexton K.C. Kastl A. Henderson J. Porten S. Waldmann J. Fassnacht M. Asa S.L. Schadendorf D. Couce M. Graefen M. Huland H. Sauter G. Schlomm T. Simon R. Tennstedt P. Olabode O. Nelson M. Bathe O. Carroll P.R. Chan J.M. Disaia P. Glenn P. Kelley R.K. Landen C.N. Phillips J. Prados M. Simko J. Smith-McCune K. VandenBerg S. Roggin K. Fehrenbach A. Kendler A. Sifri S. Steele R. Jimeno A. Carey F. Forgie I. Mannelli M. Carney M. Hernandez B. Campos B. Herold-Mende C. Jungk C. Unterberg A. von Deimling A. Bossler A. Galbraith J. Jacobus L. Knudson M. Knutson T. Ma D. Milhem M. Sigmund R. Godwin A.K. Madan R. Rosenthal H.G. Adebamowo C. Adebamowo S.N. Boussioutas A. Beer D. Giordano T. Mes-Masson A-M. Saad F. Bocklage T. Landrum L. Mannel R. Moore K. Moxley K. Postier R. Walker J. Zuna R. Feldman M. Valdivieso F. Dhir R. Luketich J. Mora Pinero E.M. Quintero-Aguilo M. Carlotti C.G. Dos Santos J.S. Kemp R. Sankarankuty A. Tirapelli D. Catto J. Agnew K. Swisher E. Creaney J. Robinson B. Shelley C.S. Godwin E.M. Kendall S. Shipman C. Bradford C. Carey T. Haddad A. Moyer J. Peterson L. Prince M. Rozek L. Wolf G. Bowman R. Fong K.M. Yang I. Korst R. Rathmell W.K. Fantacone-Campbell J.L. Hooke J.A. Kovatich A.J. Shriver C.D. DiPersio J. Drake B. Govindan R. Heath S. Ley T. Van Tine B. Westervelt P. Rubin M.A. Lee J.I. Aredes N.D. Mariamidze A. An integrated TCGA pan-cancer clinical data resource to drive high-quality survival outcome analytics. Cell 2018 173 2 400 416.e11 10.1016/j.cell.2018.02.052 29625055
    [Google Scholar]
  24. Love M.I. Huber W. Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014 15 12 550 10.1186/s13059‑014‑0550‑8 25516281
    [Google Scholar]
  25. Yu G. Wang L.G. Han Y. He Q.Y. clusterProfiler: An R package for comparing biological themes among gene clusters. OMICS 2012 16 5 284 287 10.1089/omi.2011.0118 22455463
    [Google Scholar]
  26. Subramanian A. Tamayo P. Mootha V.K. Mukherjee S. Ebert B.L. Gillette M.A. Paulovich A. Pomeroy S.L. Golub T.R. Lander E.S. Mesirov J.P. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. USA 2005 102 43 15545 15550 10.1073/pnas.0506580102 16199517
    [Google Scholar]
  27. Chen T. Zhu C. Wang X. Pan Y. LncRNA ELF3-AS1 is a prognostic biomarker and correlated with immune infiltrates in hepatocellular carcinoma. Can. J. Gastroenterol. Hepatol. 2021 2021 1 12 10.1155/2021/8323487 34336727
    [Google Scholar]
  28. Hänzelmann S. Castelo R. Guinney J. GSVA: Gene set variation analysis for microarray and RNA-Seq data. BMC Bioinformatics 2013 14 1 7 10.1186/1471‑2105‑14‑7 23323831
    [Google Scholar]
  29. Bindea G. Mlecnik B. Tosolini M. Kirilovsky A. Waldner M. Obenauf A.C. Angell H. Fredriksen T. Lafontaine L. Berger A. Bruneval P. Fridman W.H. Becker C. Pagès F. Speicher M.R. Trajanoski Z. Galon J. Spatiotemporal dynamics of intratumoral immune cells reveal the immune landscape in human cancer. Immunity 2013 39 4 782 795 10.1016/j.immuni.2013.10.003 24138885
    [Google Scholar]
  30. Yoshihara K. Shahmoradgoli M. Martínez E. Vegesna R. Kim H. Torres-Garcia W. Treviño V. Shen H. Laird P.W. Levine D.A. Carter S.L. Getz G. Stemke-Hale K. Mills G.B. Verhaak R.G.W. Inferring tumour purity and stromal and immune cell admixture from expression data. Nat. Commun. 2013 4 1 2612 10.1038/ncomms3612 24113773
    [Google Scholar]
  31. Cai H. Chen S. Wu Z. Wang F. Tang S. Li D. Wang D. Guo W. Comprehensive analysis of ZNF692 as a potential biomarker associated with immune infiltration in a pan cancer analysis and validation in hepatocellular carcinoma. Aging 2023 15 22 13041 13058 10.18632/aging.205218 37980166
    [Google Scholar]
  32. Chalmers Z.R. Connelly C.F. Fabrizio D. Gay L. Ali S.M. Ennis R. Schrock A. Campbell B. Shlien A. Chmielecki J. Huang F. He Y. Sun J. Tabori U. Kennedy M. Lieber D.S. Roels S. White J. Otto G.A. Ross J.S. Garraway L. Miller V.A. Stephens P.J. Frampton G.M. Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden. Genome Med. 2017 9 1 34 10.1186/s13073‑017‑0424‑2 28420421
    [Google Scholar]
  33. Jardim D.L. Goodman A. de Melo Gagliato D. Kurzrock R. The challenges of tumor mutational burden as an immunotherapy biomarker. Cancer Cell 2021 39 2 154 173 10.1016/j.ccell.2020.10.001 33125859
    [Google Scholar]
  34. Yamamoto H. Watanabe Y. Maehata T. Imai K. Itoh F. Microsatellite instability in cancer: A novel landscape for diagnostic and therapeutic approach. Arch. Toxicol. 2020 94 10 3349 3357 10.1007/s00204‑020‑02833‑z 32632538
    [Google Scholar]
  35. Chen B. Ding X. Wan A. Qi X. Lin X. Wang H. Mu W. Wang G. Zheng J. Comprehensive analysis of TLX2 in pan cancer as a prognostic and immunologic biomarker and validation in ovarian cancer. Sci. Rep. 2023 13 1 16244 10.1038/s41598‑023‑42171‑5 37758722
    [Google Scholar]
  36. Tyagunova E.E. Zakharov A.S. Pavlova G.V. Ogarkova D.A. Zhuchenko N.A. Gushchin V.A. A method for predicting allelic variants of single nucleotide polymorphisms. Curr. Top. Med. Chem. 2024 25 6 724 739 10.2174/0115680266328330240828040922 39238387
    [Google Scholar]
  37. Liu J. Jiang C. Xu C. Wang D. Shen Y. Liu Y. Gu L. Identification and development of a novel invasion-related gene signature for prognosis prediction in colon adenocarcinoma. Cancer Cell Int. 2021 21 1 101 10.1186/s12935‑021‑01795‑1 33579281
    [Google Scholar]
  38. Lu X. Li G. Liu S. Wang H. Zhang Z. Chen B. Bioinformatics analysis of KIF1A expression and gene regulation network in ovarian carcinoma. Int. J. Gen. Med. 2021 14 3707 3717 10.2147/IJGM.S323591 34321916
    [Google Scholar]
  39. Ding T. Shang Z. Zhao H. Song R. Xiong J. He C. Liu D. Yi B. Anoikis-related gene signatures in colorectal cancer: implications for cell differentiation, immune infiltration, and prognostic prediction. Sci. Rep. 2024 14 1 11525 10.1038/s41598‑024‑62370‑y 38773226
    [Google Scholar]
  40. Li Q. Geng S. Luo H. Wang W. Mo Y.Q. Luo Q. Wang L. Song G.B. Sheng J.P. Xu B. Signaling pathways involved in colorectal cancer: Pathogenesis and targeted therapy. Signal Transduct. Target. Ther. 2024 9 1 266 10.1038/s41392‑024‑01953‑7 39370455
    [Google Scholar]
  41. Hou C. Yang Y. Wang P. Xie H. Jin S. Zhao L. Wu G. Xing H. Chen H. Liu B. Du C. Sun X. He L. CCDC113 promotes colorectal cancer tumorigenesis and metastasis via TGF-β signaling pathway. Cell Death Dis. 2024 15 9 666 10.1038/s41419‑024‑07036‑3 39261464
    [Google Scholar]
  42. Marques A. Cavaco P. Torre C. Sepodes B. Rocha J. Tumor mutational burden in colorectal cancer: Implications for treatment. Crit. Rev. Oncol. Hematol. 2024 197 104342 10.1016/j.critrevonc.2024.104342 38614266
    [Google Scholar]
  43. Di Mauro A. Santorsola M. Savarese G. Sirica R. Ianniello M. Cossu A.M. Ceccarelli A. Sabbatino F. Bocchetti M. Carratù A.C. Pentimalli F. Ferrara G. Nasti G. Caraglia M. Ottaiano A. High tumor mutational burden assessed through next-generation sequencing predicts favorable survival in microsatellite stable metastatic colon cancer patients. J. Transl. Med. 2024 22 1 1107 10.1186/s12967‑024‑05927‑9 39639373
    [Google Scholar]
/content/journals/ctmc/10.2174/0115680266392910250728013705
Loading
Comprehensive Analysis of TSPAN11: A Potential Prognostic and Immunotherapy Biomarker in Colorectal Cancer
Bentham Science Publishers ; https://doi.org/10.2174/0115680266392910250728013705
/content/journals/ctmc/10.2174/0115680266392910250728013705
/content/journals/ctmc/10.2174/0115680266392910250728013705
Loading

Data & Media loading...

Supplements

Supplementary material is available on the publisher’s website along with the published article.

file format download Download

  • Article Type:     Research Article
Keywords: prognostic biomarker ; immune infiltration ; Colorectal cancer ; drug sensitivity ; TSPAN11 ; immunotherapy

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test